(Q43455726)

23 November 2017

title

Canadian Pseudomonas aeruginosa susceptibility study from 48 medical centers: focus on ciprofloxacin (English)

1 reference

23 November 2017

main subject

Pseudomonas aeruginosa

1 reference

Blondeau JM

1

1 reference

23 November 2017

Suter ME

series ordinal

2

1 reference

23 November 2017

Borsos S

series ordinal

3

1 reference

23 November 2017

Misfeldt C

series ordinal

4

1 reference

23 November 2017

publication date

1 November 1998

1 reference

International Journal of Antimicrobial Agents

23 November 2017

published in

1 reference

23 November 2017

volume

10

1 reference

23 November 2017

issue

4

1 reference

23 November 2017

page(s)

297-302

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900049-1

23 November 2017

1 reference

7 January 2021

Resistance development to fluoroquinolones in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900049-1

7 January 2021

Quinolone resistance. Susceptibility data from a 300-bed community hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900049-1

7 January 2021

Canadian ciprofloxacin susceptibility study: comparative study from 15 medical centers. Canadian Ciprofloxacin Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900049-1

7 January 2021

Antibiotic susceptibility profiles of 941 gram-negative bacteria isolated from septicemic patients throughout Canada. The Canadian Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900049-1

7 January 2021

Canadian ofloxacin susceptibility study: a comparative study from 18 medical centers. Canadian Ofloxacin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900049-1

7 January 2021

Study of the comparative activity of piperacillin/tazobactam with currently available antibiotics against 8206 aerobic isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900049-1

7 January 2021

10.1016/S0924-8579(98)00049-1

Identifiers

DOI

1 reference

23 November 2017

1 reference